UChicago experts contributed to two new studies which found that ambient clinical documentation tools can cut down on administrative time and help physicians be more mentally healthy and present with patients.

As the threat of antibiotic resistance grows, a Swansea University academic has led the development of a novel technology capable of killing some of the most dangerous bacteria known to medicine—with over 99.9% effectiveness against Pseudomonas aeruginosa (P. aeruginosa).

Targeting and treating diseases first requires being able to find specific cells—which is challenging because they travel within the body and can “hide.”  Now, a new round of funding will support advancing technology invented at Case Western Reserve University that enhances the ability to locate therapeutic cells or diseased cells like cancer. Toward that goal, the National Institutes of Health awarded a $2.5 million Phase II Small Business Innovation Research (SBIR) grant jointly to CWRU and BioInVision Inc.